Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India
bdtonline.com
news
2022-06-01 12:11:21

The patent was grantedby India's Office of the Controller-General of Patents, Designs and TrademarksVANCOUVER, June 01, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) ('Clearmind' or the "Company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, has been granted patent approval from the Office of the Controller-General of Patents, Designs and Trademarks in India.
